Fundz

Abram Scientific Secures $11.75M Series A Funding Led by Octapharma AG to enhance their CoagCare™ diagnostic platform for bleeding disorders.

PRIVATEFeb 25, 2026

Amount Raised

$11.8 Million

Round Type

Series A

CaliforniaBiotechnologyHealth CareMedicalMedical DeviceHealth Diagnostics

Investors

University Of Colorado AnschutzOctapharma AG

Description

Abram Scientific has announced the closing of a $11.75 million Series A financing round, led by Octapharma AG. This funding will accelerate the development of its proprietary CoagCare™ platform for evaluating blood clotting disorders. The capital will support achieving clinical milestones and FDA clearance. Abram's CoagCare System is designed to improve clinical outcomes through rapid, accurate diagnostics.

Quick answer

Abram Scientific raised $11.8 Million in a Series A round, dated February 25, 2026. Investors: University Of Colorado Anschutz and Octapharma AG. Abram Scientific is based in California, United States.

How much did Abram Scientific raise?
Abram Scientific raised $11.8 Million in a Series A round on February 25, 2026.
Who invested in Abram Scientific?
University Of Colorado Anschutz and Octapharma AG are named as investors in this round.
What does Abram Scientific do?
Abram Scientific is a medical device company focused on advancing next-generation coagulation diagnostics.
Where is Abram Scientific based and how big is it?
Abram Scientific is based in California, United States. Fundz records about 9 employees.
Who are the decision-makers at Abram Scientific?
Fundz holds 2 contacts at Abram Scientific, including the CEO, Founder. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Medical Device around the same time

Companies in the same sectors as Abram Scientific that raised within 45 days of this round, from Fundz verified event records.

  • QT Sense raised $4.7M (Funding Round) on February 4, 2026.
  • PanTera raised $4M on March 31, 2026.
  • Sub-Q Bionics raised $1.5M (Pre-Seed) on March 31, 2026.
  • Sonire Therapeutics raised $18M (Series A) on March 31, 2026.
  • IceCure Medical raised $4M on March 26, 2026.
  • Health Universe raised $6M (Seed) on March 20, 2026.

Who to call at Abram Scientific, and when

A new round usually means Abram Scientific is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Abram Scientific raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Abram Scientific, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Abram Scientific. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Abram Scientific

Location

California, United States

About

Abram Scientific is a medical device company focused on advancing next-generation coagulation diagnostics. They are developing a portable diagnostic platform, CoagCare™, to enhance patient care for bleeding disorders and critical care medicine. The CoagCare system promises rapid and accurate measurement of blood coagulation processes. Their mission is to enable life-saving therapies and transfusions for patients in critical conditions.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Abram Scientific raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsAbhishek R., CEO, Founder hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Abram Scientific's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Abram Scientific raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.